فهرست مطالب zorvan jalili

 This study aimed to assess maternal and neonatal outcomes in cases of Intrauterine Growth Restriction (IUGR). Understanding these outcomes is vital for early identification of potential adverse effects and facilitating prompt intervention and management.

 This retrospective cohort study focused on mothers whose fetuses experienced IUGR at Imam Khomeini Hospital in Ahvaz, Iran, between March 2021 and 2022. Data on neurodevelopmental and clinical aspects were collected periodically up to 24 months’ post-birth, encompassing various parameters such as infant age, gender, developmental and motor coordination disorders, neurodevelopmental status, medical and speech disorders, and maternal health during pregnancy.

 Over a one-year period, 80 breastfed infants were studied. At 6, 12, and 24 months after birth, 30% of children showed growth disorders. Boys had a slightly higher percentage of growth arrest (76.4% vs. 63.2%, P>0.05). Growth retardation was present in 13.16% of girls, compared to none of the boys. The most common medical outcomes were asthma and orthopedic disorders (5% each). Developmental disorders and motor disorders were the most common neurological and developmental outcomes, each affecting 11.25% of children. During pregnancy, 16.25% had gestational diabetes, 17.5% had hypertension, and 10% had hypothyroidism, which decreased to 6.25%, 11.25%, and 3.75%, respectively, after childbirth.

 The present study indicates a significant prevalence of growth and developmental disorders, as well as medical outcomes such as asthma and orthopedic issues at the age of two in infants with IUGR. Mothers of these infants also faced significant postpartum issues, such as diabetes and hypertension.

Placenta accreta spectrum (PAS) is a major cause of obstetric bleeding in third trimester of pregnancy.

This study aimed to compare the outcomes of uterine preservation surgery vs. hysterectomy in women with PAS.

In this retrospective cross-sectional study, the records of 68 women with PAS referred to the Imam Khomeini hospital in Ahvaz, Iran, between March 2015 and February 2020 were included. The women divided into 2 groups according to surgical approach: hysterectomy vs. uterine preservation (including just removing the lower segment, removing the lower segment with uterine artery ligation or removing the lower segment with hypogastric artery ligation during cesarean section). The need for blood components transfusion (whole blood, packed cells, and fresh frozen plasma), maternal mortality, duration of surgery, and length of hospitalization was compared between groups.

In total, we investigated 68 women between the ages of 24-45 yr (mean age of 32.88 ± 5.08 yr). All participants were multiparous and underwent cesarean section. Furthermore, 28 women (41.2%) had a history of curettage. In total, 24 women (35.3%) underwent hysterectomy, and 44 (64.7%) underwent uterine preservative surgeries. There were no significant differences between groups of hysterectomy and uterine preservative surgeries in terms of need for blood components transfusion, maternal mortality, duration of surgery, and length of hospitalization.

The results of this study showed no significant difference between groups regarding the studied outcomes. Therefore, conservative surgeries could be used to preserve the uterus instead of hysterectomy in women with PAS.